标题
Biomarkers for prostate cancer: prostate-specific antigen and beyond
作者
关键词
-
出版物
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
Volume -, Issue -, Pages -
出版商
Walter de Gruyter GmbH
发表日期
2019-11-12
DOI
10.1515/cclm-2019-0693
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer
- (2019) Karim Fizazi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study
- (2019) Andrew J. Armstrong et al. JOURNAL OF CLINICAL ONCOLOGY
- A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer
- (2019) Jonas Hugosson et al. EUROPEAN UROLOGY
- Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019
- (2019) Giorgio Gandaglia et al. EUROPEAN UROLOGY
- Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening
- (2018) Robert A. Smith et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Management of Men with Prostate-specific Antigen Failure After Prostate Radiotherapy: The Case Against Early Androgen Deprivation
- (2018) Douglas Brand et al. EUROPEAN UROLOGY
- Early Androgen Deprivation Therapy Improves Survival, But How Do We Determine in Whom?
- (2018) Mark Frydenberg et al. EUROPEAN UROLOGY
- Time for a “Radical” Change to Active Surveillance for Prostate Cancer?
- (2018) Jenny L. Donovan et al. EUROPEAN UROLOGY
- Clinical and Genomic Characterization of Low–Prostate-specific Antigen, High-grade Prostate Cancer
- (2018) Brandon A. Mahal et al. EUROPEAN UROLOGY
- Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
- (2018) Silke Gillessen et al. EUROPEAN UROLOGY
- Prostate-Specific Antigen–Based Screening for Prostate Cancer
- (2018) Joshua J. Fenton et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality
- (2018) Richard M. Martin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel
- (2018) Lauren C. Harshman et al. JOURNAL OF CLINICAL ONCOLOGY
- Optimizing Anticancer Therapy in Metastatic Non-Castrate Prostate Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- (2018) Michael J. Morris et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: A Comparison With Prostate-Specific Antigen Across Five Randomized Phase III Clinical Trials
- (2018) Glenn Heller et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options
- (2018) Martin G. Sanda et al. JOURNAL OF UROLOGY
- Value of free/total prostate-specific antigen (f/t PSA) ratios for prostate cancer detection in patients with total serum prostate-specific antigen between 4 and 10 ng/mL
- (2018) Yan Huang et al. MEDICINE
- Clinical implications of PTEN loss in prostate cancer
- (2018) Tamara Jamaspishvili et al. Nature Reviews Urology
- Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer
- (2018) Maha Hussain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer
- (2018) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Results of Prostate Cancer Screening in a Unique Cohort at 19 yr of Follow-up
- (2018) Daniël F. Osses et al. EUROPEAN UROLOGY
- Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review
- (2018) Thomas Van den Broeck et al. EUROPEAN UROLOGY
- Evaluation of New Tests and Interventions for Prostate Cancer Management: A Systematic Review
- (2018) Ghadeer Olleik et al. Journal of the National Comprehensive Cancer Network
- Re: Reevaluating PSA Testing Rates in the PLCO Trial
- (2017) Peter Albers EUROPEAN UROLOGY
- Intratumoral and Intertumoral Genomic Heterogeneity of Multifocal Localized Prostate Cancer Impacts Molecular Classifications and Genomic Prognosticators
- (2017) Lei Wei et al. EUROPEAN UROLOGY
- EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer
- (2017) Philip Cornford et al. EUROPEAN UROLOGY
- EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
- (2017) Nicolas Mottet et al. EUROPEAN UROLOGY
- Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide
- (2017) Emmanuel S. Antonarakis et al. JOURNAL OF CLINICAL ONCOLOGY
- Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease
- (2017) Daniel E. Spratt et al. JOURNAL OF CLINICAL ONCOLOGY
- Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
- (2017) Hashim U Ahmed et al. LANCET
- Prostate Cancer Screening — A Perspective on the Current State of the Evidence
- (2017) Paul F. Pinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic role of Ki-67 score in localized prostate cancer: A systematic review and meta-analysis
- (2017) Alejandro Berlin et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment
- (2016) Scott A. Tomlins et al. EUROPEAN UROLOGY
- Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker–Based Risk Score
- (2016) Leander Van Neste et al. EUROPEAN UROLOGY
- A Four-kallikrein Panel Predicts High-grade Cancer on Biopsy: Independent Validation in a Community Cohort
- (2016) Katharina Braun et al. EUROPEAN UROLOGY
- Prostate-Specific Antigen Screening: Time to Change the Dominant Forces on the Pendulum
- (2016) Jonathan E. Shoag et al. JOURNAL OF CLINICAL ONCOLOGY
- Evidence-Based Versus Personalized Prostate Cancer Screening: Using Baseline Prostate-Specific Antigen Measurements to Individualize Screening
- (2016) Stacy Loeb JOURNAL OF CLINICAL ONCOLOGY
- Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
- (2016) Howard I. Scher et al. JOURNAL OF CLINICAL ONCOLOGY
- Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis
- (2016) Shuang G Zhao et al. LANCET ONCOLOGY
- Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer
- (2016) Jenny L. Donovan et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening
- (2016) Andrew J. Vickers et al. UROLOGY
- The Prostate Health Index adds predictive value to multi-parametric MRI in detecting significant prostate cancers in a repeat biopsy population
- (2016) V. J. Gnanapragasam et al. Scientific Reports
- Evaluation of prostate cancer antigen 3 for detecting prostate cancer: a systematic review and meta-analysis
- (2016) Yong Cui et al. Scientific Reports
- Genomic Alterations in Cell-Free DNA and Enzalutamide Resistance in Castration-Resistant Prostate Cancer
- (2016) Alexander W. Wyatt et al. JAMA Oncology
- Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort
- (2015) J Cuzick et al. BRITISH JOURNAL OF CANCER
- Development and Clinical Validation of an In Situ Biopsy-Based Multimarker Assay for Risk Stratification in Prostate Cancer
- (2015) P. Blume-Jensen et al. CLINICAL CANCER RESEARCH
- A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer
- (2015) Jennifer Cullen et al. EUROPEAN UROLOGY
- PCA3 in prostate cancer and tumor aggressiveness detection on 407 high-risk patients: a National Cancer Institute experience
- (2015) Roberta Merola et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Multicenter Evaluation of the Prostate Health Index to Detect Aggressive Prostate Cancer in Biopsy Naïve Men
- (2015) Claire de la Calle et al. JOURNAL OF UROLOGY
- The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer
- (2015) Stacy Loeb et al. JOURNAL OF UROLOGY
- Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study
- (2015) Henrik Grönberg et al. LANCET ONCOLOGY
- Urinary PCA3 and TMPRSS2:ERG reduce the need for repeat biopsy
- (2015) Peter Sidaway Nature Reviews Urology
- DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
- (2015) Joaquin Mateo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preoperative prostate health index is an independent predictor of early biochemical recurrence after radical prostatectomy: Results from a prospective single-center study
- (2015) Giovanni Lughezzani et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis
- (2014) K. S. Louie et al. ANNALS OF ONCOLOGY
- A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling
- (2014) Eric A. Klein et al. EUROPEAN UROLOGY
- Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer?
- (2014) John T. Wei et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Validation of an Epigenetic Assay to Predict Negative Histopathological Results in Repeat Prostate Biopsies
- (2014) Alan W. Partin et al. JOURNAL OF UROLOGY
- Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
- (2014) Fritz H Schröder et al. LANCET
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mortality and complications after prostate biopsy in the Prostate, Lung, Colorectal and Ovarian Cancer Screening (PLCO) trial
- (2013) Paul F. Pinsky et al. BJU INTERNATIONAL
- The utility of prostate-specific antigen in the management of advanced prostate cancer
- (2013) E. David Crawford et al. BJU INTERNATIONAL
- Serum Isoform [−2]proPSA Derivatives Significantly Improve Prediction of Prostate Cancer at Initial Biopsy in a Total PSA Range of 2–10 ng/ml: A Multicentric European Study
- (2013) Massimo Lazzeri et al. EUROPEAN UROLOGY
- Head-to-Head Comparison of Prostate Health Index and Urinary PCA3 for Predicting Cancer at Initial or Repeat Biopsy
- (2013) Vincenzo Scattoni et al. JOURNAL OF UROLOGY
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
- (2013) C. Parker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prostate cancer screening and the management of clinically localized disease
- (2013) T. J. Wilt et al. BMJ-British Medical Journal
- Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer
- (2012) Meelan Bul et al. BJU INTERNATIONAL
- Prostate-specific antigen kinetics as a surrogate endpoint in clinical trials of metastatic castration-resistant prostate cancer: A review
- (2012) G. Colloca CANCER TREATMENT REVIEWS
- Multicenter Evaluation of [-2]Proprostate-Specific Antigen and the Prostate Health Index for Detecting Prostate Cancer
- (2012) C. Stephan et al. CLINICAL CHEMISTRY
- Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up
- (2012) G. L. Andriole et al. JNCI-Journal of the National Cancer Institute
- A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy
- (2011) Marco Auprich et al. BJU INTERNATIONAL
- A Panel of Kallikrein Marker Predicts Prostate Cancer in a Large, Population-Based Cohort Followed for 15 Years without Screening
- (2011) A. J. Vickers et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- False-positive screening results in the European randomized study of screening for prostate cancer
- (2011) Tuomas P. Kilpeläinen et al. EUROPEAN JOURNAL OF CANCER
- Prostate-Specific Antigen (PSA) Isoform p2PSA in Combination with Total PSA and Free PSA Improves Diagnostic Accuracy in Prostate Cancer Detection
- (2010) Flip H. Jansen et al. EUROPEAN UROLOGY
- Critical Assessment of Preoperative Urinary Prostate Cancer Antigen 3 on the Accuracy of Prostate Cancer Staging
- (2010) Marco Auprich et al. EUROPEAN UROLOGY
- Reducing Unnecessary Biopsy During Prostate Cancer Screening Using a Four-Kallikrein Panel: An Independent Replication
- (2010) Andrew Vickers et al. JOURNAL OF CLINICAL ONCOLOGY
- Short-term outcomes of the prospective multicentre ‘Prostate Cancer Research International: Active Surveillance’ study
- (2009) Roderick C.N. van den Bergh et al. BJU INTERNATIONAL
- Risk Assessment for Prostate Cancer Metastasis and Mortality at the Time of Diagnosis
- (2009) Matthew R. Cooperberg et al. JNCI-Journal of the National Cancer Institute
- Mortality Results from a Randomized Prostate-Cancer Screening Trial
- (2009) Gerald L. Andriole et al. NEW ENGLAND JOURNAL OF MEDICINE
- Screening and Prostate-Cancer Mortality in a Randomized European Study
- (2009) Fritz H. Schröder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Predictive value of PCA3 in urinary sediments in determining clinico-pathological characteristics of prostate cancer
- (2009) Daphne Hessels et al. PROSTATE
- A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden
- (2008) Andrew J Vickers et al. BMC Medicine
- National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
- (2008) C. M. Sturgeon et al. CLINICAL CHEMISTRY
- Prostate Specific Antigen Working Group Guidelines on Prostate Specific Antigen Doubling Time
- (2008) Philip M. Arlen et al. JOURNAL OF UROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation